RNAC
Cartesian Therapeutics Inc.
$9.70
+$0.38(+4.02%)
44
Overall
60
Value
20
Tech
52
Quality
Market Cap
$253.26M
Volume
30.50K
52W Range
$8.46 - $26.50
Target Price
$36.43
Key Metrics Overview
| Market Cap | $253.26M | P/E Ratio | N/A |
| 52W High | $26.50 | 52W Low | $8.46 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -173.1% | 52W Position | 6.8% |
| Overall Score | 44 | Value Score | 60 |
| Quality Score | 52 | Technical Score | 20 |
Growth Analysis
| EPS Current Est | $-2.11 | EPS Next Est | $-3.49 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNAC | $9.70 | +4.0% | 30.50K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cartesian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW